Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA35 for Treatment of Chronic Wounds
NCT05764226Completed
- Sponsor
- Nakhia Impex LLC
- Start
- Jul 2020
- Primary completion
- Dec 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in Chronic wound, sponsored by Nakhia Impex LLC. Primary endpoint: The pain score at 24 hours. Started Jul 2020; status: completed.
02
Drugs
ha35
03
Conditions
Chronic wound
Beyond the preview
Go deeper on NCT05764226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05764226.